Penserra Capital Management LLC Vincerx Pharma, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.0 - $0.0 $0 - $0	3,870 Added 137.77%	6,679 $8,000
Q1 2022 May 13, 2022	BUY	$0.0 - $0.0 $0 - $0	561 Added 24.96%	2,809 $11,000
Q4 2021 Feb 15, 2022	BUY	$0.0 - $0.0 $0 - $0	2,248 New	2,248 $22,000
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.0 $0 - $0	-3,312 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$0.0 - $27.0 $0 - $10,962	-406 Reduced 10.92%	3,312 $43,000
Q1 2021 May 13, 2021	BUY	$22.6 - $31.0 $84,026 - $115,258	3,718 New	3,718 $71,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.